Vanita G Chawla, M,D, MPH
Psychiatry · Mountain View
- Medicare standing
- 3 flags on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Accusation Filed
- 2 Medical Board actions on record
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Vanita G Chawla’s office at (650) 266-8213 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A79515 · Current
Licensed to practise in California · since 2002 · expires 2028-05-31 · Tulane University School of Medicine. Board flags: Accusation Filed, Misdemeanor Conviction.
Public record actions
| 2026-03-23 | Board disciplineDiscipline | Accusation filed. the physician has not had a hearing or been found guilty of any charges. · 8002025120862 |
| 2026-01-08 | Misdemeanor convictionDiscipline | Pled nolo contendere to one count of violating vehicle code ? 23101A/23103.5, wet reckless. · Superior court of california, county of santa clara · B250447 |
Drugs they prescribed that Part D paid
$573
Pharmacies billed $573 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 48) in 2024. Too few prescriptions to compare fairly with other clinicians.
48 generic and 0 brand-name prescriptions · $573 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lamotrigine | 12 | $65 | $5 |
| Clonazepam | 13 | $50 | $4 |
Year by year
| 2024 | 48 | None | 0% (0) | 0% | $573 |
| 2023 | 48 | None | 0% (0) | 0% | $327 |
| 2022 | 35 | None | 0% (0) | None | $301 |
| 2021 | 36 | None | 0% (0) | 0% | $252 |
| 2018 | 47 | None | 0% (0) | None | $1,432 |
| 2017 | 36 | None | 0% (0) | None | $9,958 |
| 2016 | 56 | None | 0% (0) | 0% | $1,098 |
| 2015 | 139 | None | 0% (0) | None | $5,105 |
| 2014 | 45 | None | 0% (0) | 0% | $2,826 |
| 2013 | 51 | None | 0% (0) | 33% | $4,678 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Clonazepam | 13 | $82 | $6 |
| Lamotrigine | 12 | $56 | $5 |
2018: 1 drug
| Duloxetine | 14 | $407 | $29 |
2017: 1 drug
| Duloxetine | 14 | $508 | $36 |
2016: 1 drug
| Warfarin | 18 | $174 | $10 |
2015: 3 drugs
| Duloxetine | 12 | $1,295 | $108 |
| Bupropion Hcl Sr | 18 | $481 | $27 |
| Lamotrigine | 27 | $347 | $13 |
2014: 2 drugs
| Duloxetine | 13 | $2,613 | $201 |
| Lorazepam | 12 | $50 | $4 |
2013: 2 drugs
| Cymbalta | 16 | $3,881 | $243 |
| Lorazepam | 11 | $73 | $7 |
Money from drug and device companies
$125 in 2024
| 2024 | 1 | 1 | None | $125 |
| 2023 | 2 | 2 | None | $248 |
| 2021 | 1 | 2 | None | $234 |
| 2019 | 1 | 1 | None | $13 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $125 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2024-12-03 | Cobenfy | $125 |
See earlier years (2023, 2021, 2019)
2023: $248
| Otsuka America Pharmaceutical | Rexulti | $125 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $124 | 1 payment
|
2021: $234
| AbbVie | Vraylar | $234 | 2 payments
|
2019: $13
| Allergan | Vraylar | $13 | 1 payment
|
Professional record
- NPI
- 1548449135
- Licence
- CA A79515California A79515: Current · expires 2028-05-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 1059 El Monte Ave, Suite B, Mountain View, CA, 94040
- NPI first listed
- 2007-10-30
- NPI last updated
- 2007-10-30
This is when the NPI record was last certified, not a medical board exam.